METASTASIS
Clinical trials for METASTASIS explained in plain language.
Never miss a new study
Get alerted when new METASTASIS trials appear
Sign up with your email to follow new studies for METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for KRAS lung cancer? drug duo enters phase 2 trial
Disease control Not yet recruitingThis study tests a combination of two drugs, luvometinib and anlotinib, in people with a specific type of advanced lung cancer (KRAS-mutated non-small cell lung cancer) that has worsened after prior treatment. The goal is to see if the combo can shrink tumors. About 48 adults age…
Matched conditions: METASTASIS
Phase: PHASE2 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated May 26, 2026 04:29 UTC
-
Surgery plus drugs may extend life in advanced liver cancer, new trial to find out
Disease control Not yet recruitingThis study looks at people with liver cancer that has spread outside the liver. It tests whether surgically removing the main liver tumor, along with standard drug therapy, helps them live longer compared to drug therapy alone. About 280 adults aged 18-75 with a resectable liver …
Matched conditions: METASTASIS
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 20, 2026 11:57 UTC